| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 17, 2023 | PSNL Personalis, Inc. | Tachibana Aaron68 | CFO And COO | Sell | 3,945 | $2.83 | $11,164.35 | -1.9% | -21.2% | -41.0% | |
| Mar 17, 2023 | PSNL Personalis, Inc. | Chen Richard70 | Chief Medical Officer And EVP | Sell | 1,314 | $2.83 | $3,718.62 | -1.0% | -21.2% | -41.0% | |
| Mar 16, 2023 | RDNT Radnet, Inc. | Forthuber Stephen M49 | Pres &Coo-eastern Operations | Sell | 10,000 | $23.02 | $230,168.00 | -1.9% | +25.8% | +86.1% | |
| Mar 16, 2023 | VCYT Veracyte, Inc. | Eastham Karin67 | Director | Sell | 18,750 | $22.78 | $427,044.38 | -44.4% | +13.3% | -9.5% | |
| Mar 15, 2023 | VCYT Veracyte, Inc. | Anderson Bonnie H72 | Director | Sell | 34,000 | $22.76 | $773,887.60 | -38.7% | +17.8% | -7.2% | |
| Mar 15, 2023 | GH Guardant Health, Inc. | Eltoukhy Helmy76 | Co-chief Executive Officer | Buy | 93,052 | $26.32 | $2,448,836.14 | +2.3% | +40.6% | -31.4% | |
| Mar 14, 2023 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 8,372 | $20.95 | $175,426.89 | -1.7% | -32.1% | -8.4% | |
| Mar 14, 2023 | NOTV Inotiv, Inc. | Sagartz John E60 | Chief Strategy Officer | Buy | 5,100 | $4.91 | $25,041.00 | +0.7% | +10.8% | +75.1% | |
| Mar 14, 2023 | TMO Thermo Fisher Scientific Inc. | Casper Marc N59 | Chairman &CEO | Sell | 15,000 | $549.14 | $8,237,145.53 | -1.0% | -5.8% | +6.7% | |
| Mar 14, 2023 | GH Guardant Health, Inc. | Talasaz Amirali | Co-chief Executive Officer | Buy | 97,000 | $25.79 | $2,501,183.21 | +1.7% | +30.1% | -28.8% | |
| Mar 10, 2023 | WGS Genedx Holdings Corp. | Feeley Kevin46 | Chief Financial Officer | Sell | 31,876 | $0.36 | $11,468.98 | -29.0% | -40.8% | -25.9% | |
| Mar 10, 2023 | WGS Genedx Holdings Corp. | Saad Kareem61 | Chief Transformation Officer | Sell | 35,200 | $0.36 | $12,664.96 | -16.5% | -40.8% | -25.9% | |
| Mar 10, 2023 | WGS Genedx Holdings Corp. | White Karen Ann77 | Chief People Officer | Sell | 32,787 | $0.36 | $11,796.76 | -38.6% | -40.8% | -25.9% | |
| Mar 10, 2023 | WGS Genedx Holdings Corp. | Stueland Katherine | Chief Executive Officer | Sell | 92,644 | $0.36 | $33,333.31 | -23.1% | -40.8% | -25.9% | |
| Mar 9, 2023 | WST West Pharmaceutical Services Inc | Abraham Silji62 | SVP, Chief Technology Officer | Sell | 1,500 | $322.57 | $483,850.05 | -26.3% | +9.4% | +14.1% | |
| Mar 8, 2023 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 1,000,000 | $1.18 | $1,175,384.34 | - | +34.5% | -15.8% | |
| Mar 8, 2023 | BIO Bio-Rad Laboratories, Inc. | Ernst Timothy S69 | EVP, General Counsel &Sec | Sell | 1,746 | $486.43 | $849,299.94 | -22.3% | -22.9% | -29.5% | |
| Mar 7, 2023 | WST West Pharmaceutical Services Inc | Green Eric Mark57 | President &CEO | Sell | 44,000 | $322.35 | $14,183,530.86 | -7.8% | +6.8% | +10.4% | |
| Mar 6, 2023 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 8,372 | $24.71 | $206,855.38 | -1.7% | -52.0% | -8.1% | |
| Mar 3, 2023 | EXAS Exact Sciences Corp | Orville Jacob A76 | General Manager, Screening | Sell | 5,000 | $65.00 | $325,000.00 | -30.4% | +24.2% | -12.0% | |
| Mar 3, 2023 | RDNT Radnet, Inc. | Villigerwilson Ruth Louisa51 | Director | Sell | 17,776 | $24.94 | $443,248.12 | -64.3% | +18.7% | +76.9% | |
| Mar 3, 2023 | CSTL Castle Biosciences Inc | Bradbury Daniel69 | Director | Sell | 25,000 | $23.97 | $599,269.79 | -2.3% | -14.7% | -19.2% | |
| Mar 3, 2023 | GH Guardant Health, Inc. | Kalia Kumud61 | Chief Information Officer | Sell | 6,500 | $31.92 | $207,466.35 | -83.8% | -2.2% | -40.9% | |
| Mar 2, 2023 | MYGN Myriad Genetics Inc | Lambert Nicole71 | Chief Operating Officer | Sell | 13,184 | $22.74 | $299,822.62 | -5.8% | -3.7% | -3.1% | |
| Mar 2, 2023 | XGN Exagen Inc. | Adawi Kamal | CFO And Corporate Secretary | Sell | 3,667 | $2.30 | $8,431.53 | -1.9% | +27.5% | -14.4% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.